AAAAAA

   
Results: 1-11 |
Results: 11
Synthesis and erythropoietin receptor binding affinities of N,N-disubstituted amino acids
Authors: Connolly, PJ Wetter, SK Murray, WV Johnson, DL McMahon, FJ Farrell, FX Tullai, J Jolliffe, LK
Citation: Pj. Connolly et al., Synthesis and erythropoietin receptor binding affinities of N,N-disubstituted amino acids, BIOORG MED, 10(17), 2000, pp. 1995-1999
Erythropoietin mimetic peptides and the future
Authors: Johnson, DL Jolliffe, LK
Citation: Dl. Johnson et Lk. Jolliffe, Erythropoietin mimetic peptides and the future, NEPH DIAL T, 15(9), 2000, pp. 1274-1277
An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists
Authors: Pulito, VL Li, XB Varga, SS Mulcahy, LS Clark, KS Halbert, SA Reitz, AB Murray, WV Jolliffe, LK
Citation: Vl. Pulito et al., An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists, J PHARM EXP, 294(1), 2000, pp. 224-229
In vitro characterization of five humanized OKT3 effector function variantantibodies
Authors: Xu, DL Alegre, ML Varga, SS Rothermel, AL Collins, AM Pulito, VL Hanna, LS Dolan, KP Parren, PWHI Bluestone, JA Jolliffe, LK Zivin, RA
Citation: Dl. Xu et al., In vitro characterization of five humanized OKT3 effector function variantantibodies, CELL IMMUN, 200(1), 2000, pp. 16-26
Application of virtual screening tools to a protein-protein interaction: Database mining studies on the growth hormone receptor
Authors: Loughney, DA Murray, WV Jolliffe, LK
Citation: Da. Loughney et al., Application of virtual screening tools to a protein-protein interaction: Database mining studies on the growth hormone receptor, MED CHEM RE, 9(7-8), 1999, pp. 579-591
The structure, organization, activation and plasticity of the erythropoietin receptor
Authors: Wilson, IA Jolliffe, LK
Citation: Ia. Wilson et Lk. Jolliffe, The structure, organization, activation and plasticity of the erythropoietin receptor, CURR OP STR, 9(6), 1999, pp. 696-704
New epoetin molecules and novel therapeutic approaches
Authors: Barbone, FP Johnson, DL Farrell, FX Collins, A Middleton, SA McMahon, FJ Tullai, J Jolliffe, LK
Citation: Fp. Barbone et al., New epoetin molecules and novel therapeutic approaches, NEPH DIAL T, 14, 1999, pp. 80-84
Using affinity capillary electrophoresis to study the interaction of the extracellular binding domain of erythropoietin receptor with peptides
Authors: Caldwell, GW McDonnell, PA Masucci, JA Johnson, DL Jolliffe, LK
Citation: Gw. Caldwell et al., Using affinity capillary electrophoresis to study the interaction of the extracellular binding domain of erythropoietin receptor with peptides, J BIOCH BIO, 40(1-2), 1999, pp. 17-25
Phase I trial of a humanized, fc receptor nonbinding OKT3 antibody, huOKT3gamma(1)(Ala-Ala) in the treatment of acute renal allograft rejection
Authors: Woodle, ES Xu, DL Zivin, RA Auger, J Charette, J O'Laughlin, R Peace, D Jolliffe, LK Haverty, T Bluestone, JA Thistlethwaite, JR
Citation: Es. Woodle et al., Phase I trial of a humanized, fc receptor nonbinding OKT3 antibody, huOKT3gamma(1)(Ala-Ala) in the treatment of acute renal allograft rejection, TRANSPLANT, 68(5), 1999, pp. 608-616
Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
Authors: Livnah, O Stura, EA Middleton, SA Johnson, DL Jolliffe, LK Wilson, LA
Citation: O. Livnah et al., Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation, SCIENCE, 283(5404), 1999, pp. 987-990
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide
Authors: Middleton, SA Barbone, FP Johnson, DL Thurmond, RL You, Y McMahon, FJ Jin, RZ Livnah, O Tullai, J Farrell, FX Goldsmith, MA Wilson, IA Jolliffe, LK
Citation: Sa. Middleton et al., Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide, J BIOL CHEM, 274(20), 1999, pp. 14163-14169
Risultati: 1-11 |